A+ Science’s first accredited CME event within endocrinology

December 06, 2011

This event will take place on 6th of December during the World Diabetes Congress, 2011 in Dubai. The educational programme is organised by Umeå University Hospital, Course Director: Prof. Tommy Olsson, Umeå, Sweden

Title: SGLT2 inhibition – a new therapeutic approach to the management of Type 2 diabetes mellitus (T2DM)
Venue: Dubai International Convention & Exhibition Centre, Room: Sheikh Maktoum A
Date: 6 December 2011, 18.00-20.00
Course Director: Prof. Tommy Olsson


Educational objectives of this event is
To review the current issues in Type 2 diabetes:
• The long term effects of glucotoxicity
• Disease progression and co-morbidities
• Limitations of current treatments and the need for new modalities

To understand the developmental history of SGLT2 inhibitors and their mode action and  pharmacodynamic effects, in particular:
• The role of the kidney in homeostasis including SGLT 1 & 2
• Early SGLT2 inhibitors and their failings
• Mode of action of current SGLT2 inhibitors
• Characteristics of urinary glucose excretion with SGLT2 inhibitors

To develop an understanding of the clinical potential for SGLT2 inhibitors across the disease spectrum in Type 2 diabetes by reviewing available data for compounds currently in development including:

• Initial monotherapy & combination therapy
• Add-on to current treatments, such as metformin, sulfonylureas,     thiazolidinediones and insulin
• Efficacy across the spectrum of disease
• Tolerability and safety of SGLT2 inhibitors

Learning outcomes
At the end of the program, participants will be able to describe the role of the sodium-glucose co-transporter 2 (SGLT2) in normal physiology and in diabetes. Participants will be able to describe clinical data on responses to SGLT2 inhibitors across the spectrum of disease.

Target audience (up to 650 attendees)
This educational programme is intended for clinicians who have an interest in the diagnosis and treatment of patients with Type 2 diabetes, including general medical physicians, endocrinologists and diabetologists.


Return to eventlist